Artax Biopharma Appoints Joseph Lobacki as CEO

Autoimmune Disease Company Hires Life Science Industry Experts to Lead Company Through Next Stage into Human Clinical Studies with Novel Oral... Read More
The manufacturing challenge for AAV genetherapy

Editorial MedpageToday talks about Gene therapy and its challenges Read complete article here: https://www.medpagetoday.com/special-reports/exclusives/84956 Read More
Aura Biosciences presents updated clinical data for AU-011

Aura Biosciences presents updated phase 1b/2 clinical data for AU-011 at the 43rd Annual Macula Society Meeting Light-Activated AU-011 Holds Significant... Read More
Basque Country as the most attractive European region for foreign investment

The Financial Times ranks the Basque Country as the most attractive mid-sized European region for foreign direct investment strategy For the... Read More
Valuable in-kind donation from Viralgen for Gene Therapy research

Viralgen Vector Core, the leading GMP manufacturer of adeno associated virus, has recently donated a large in kind donation to Columbus... Read More
Quirónsalud treats the first patient with protontherapy in Spain

Quirónsalud treated the first patient in Spain with proton therapy at his Proton Therapy Center in Madrid https://www.quironsalud.es/es/comunicacion/notas-prensa/quironsalud-trata-primer-paciente-espana-terapia-protones Read More
First patient dosed in pivotal phase 3 trial of SNF472 in calciphylaxis

First patient dosed in phase 3 trial of SNF472 for the treatment of calcific uremic arteriolopathy (CUA) or calciphylaxis   Palma,... Read More
Aura Biosciences Appoints George Golumbeski, Ph.D., as Chairman of the BOD

Aura Biosciences Appoints George Golumbeski, Ph.D., as Chairman of the Board of Directors   CAMBRIDGE, Mass.-- Aura Biosciences, a clinical-stage biopharmaceutical... Read More